Study: Medicare spends millions on cancer treatments without clinical benefit

Medicare spent nearly $600 million over a three-year period for cancer care involving four Food and Drug Administration-approved drugs later found to provide no clinical benefit for certain forms of the disease.

Share on FacebookEmail this to someoneShare on Google+Tweet about this on TwitterPrint this pageShare on LinkedInShare on StumbleUponShare on TumblrShare on RedditFlattr the authorPin on PinterestBuffer this pageDigg this